Cleared Traditional

K170195 - QuantX

K170195 is an FDA 510(k) clearance for QuantX, manufactured by Quantitative Insights, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 114-day FDA review.

K170195 · Quantitative Insights, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2017
Decision
114d
Days
Class 2
Risk

K170195 is an FDA 510(k) clearance for the QuantX. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Quantitative Insights, Inc. (Chicago, US). The FDA issued a Cleared decision on May 17, 2017 after a review of 114 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Quantitative Insights, Inc. devices

FDA 510(k) Submission Details - K170195

510(k) Number K170195 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2017
Decision Date May 17, 2017
Days to Decision 114 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 107d · This submission: 114d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1766
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K170195.
vascuCAP
K163071 · Elucid Bioimaging, Inc. · May 2017
UNiD Spine Analyzer
K170172 · Medicrea International · May 2017
Dynamika
K161601 · Image Analysis Limited · May 2017
Longitudinal Brain Imaging (LoBI) application
K163250 · Philips Medical Systems Nederland B.V. · May 2017
Lung Vision
K163622 · Bodyvision Medical , Ltd. · May 2017
SurgiCase Viewer
K170419 · Materialise NV · May 2017